Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma-Reference-Cited by-同舟云学术

Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma

Published:2021-10 Issue: Volume:160 Page:44-49
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Steendam Christi M.J.,Peric Robert,van Walree Nico C.,Youssef Magdolen,Schramel Franz M.N.H.,Brocken Pepijn,van Putten John W.G.,van der Noort Vincent,Veerman G.D. Marijn,Koolen Stijn L.W.,Groen Harry J.M.,Dingemans Anne-Marie C.,Mathijssen Ron H.J.,Smit Egbert F.,Aerts Joachim G.J.V.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018

2. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N. Engl. J. Med.,2005

3. Epidermal growth factor receptor targeting in cancer;Mendelsohn;Semin. Oncol.,2006

4. Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation;Mahaffey;Clin. Lung Cancer.,2007

5. Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS;Furugaki;Oncol. Rep.,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Size-Controlled Preparation of Docetaxel- and Curcumin-Loaded Nanoemulsions for Potential Pulmonary Delivery;Pharmaceutics;2023-02-15